Literature DB >> 19551238

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection.

David W Dowdy1, Richard E Chaisson.   

Abstract

OBJECTIVE: To investigate whether short-term annual declines of 5-10% in the incidence of tuberculosis (TB) can be sustained over the long term by maintaining high case detection rates (CDRs).
METHODS: We constructed a compartmental difference-equation model of a TB epidemic in a hypothetical population of constant size with a treatment success rate of 85%. The impact of CDR on TB incidence was then investigated by generating an equilibrium population with no TB case detection and increasing the smear-positive CDR under two scenarios: (i) rapid expansion by 10% per year to a CDR of 80% after 8 years, and (ii) gradual expansion by 1% per year to a CDR of 90% after 90 years. The model was applied in two hypothetical populations: one without HIV and the other with a stable HIV incidence representative of the African Region. The CDR for smear-negative TB was assumed to be a constant fraction of the smear-positive CDR.
FINDINGS: In the absence of a TB control programme, the projected annual incidence of TB was 513 cases per 100 000 population, with a point prevalence of 1233 per 100 000 and an annual TB-specific mortality rate of 182 per 100 000. Immediately increasing the TB CDR from 0% to 70% caused a 74% reduction in TB incidence within 10 years. However, once case detection stabilized at any constant level < 80%, projected TB incidence also stabilized. Ten years after a CDR of 70% was reached, the annual decline in TB incidence was < 1.5%, regardless of how rapidly case detection was scaled up and despite wide variation of all model parameters.
CONCLUSION: While improved CDRs have a dramatic short-term effect on TB incidence, maintaining those rates, even at current target levels, may not reduce long-term incidence by more than 1-2% per year. TB control programmes and researchers should vigorously pursue improvements in case detection, regardless of current CDRs.

Entities:  

Mesh:

Year:  2009        PMID: 19551238      PMCID: PMC2672581          DOI: 10.2471/blt.08.054510

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  30 in total

Review 1.  The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis.

Authors:  Peter D O Davies
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

2.  Controlling tuberculosis in India.

Authors:  G R Khatri; Thomas R Frieden
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

Review 3.  Controlled chemoprophylaxis trials in tuberculosis. A general review.

Authors:  S H Ferebee
Journal:  Bibl Tuberc       Date:  1970

4.  Assessing health seeking behaviour among tuberculosis patients in rural South Africa.

Authors:  R M Pronyk; M B Makhubele; J R Hargreaves; S M Tollman; H P Hausler
Journal:  Int J Tuberc Lung Dis       Date:  2001-07       Impact factor: 2.373

Review 5.  Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.

Authors:  Martien W Borgdorff; Katherine Floyd; Jaap F Broekmans
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

6.  Control strategies for tuberculosis epidemics: new models for old problems.

Authors:  S M Blower; P M Small; P C Hopewell
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

7.  A nationally representative case-control study of smoking and death in India.

Authors:  Prabhat Jha; Binu Jacob; Vendhan Gajalakshmi; Prakash C Gupta; Neeraj Dhingra; Rajesh Kumar; Dhirendra N Sinha; Rajesh P Dikshit; Dillip K Parida; Rajeev Kamadod; Jillian Boreham; Richard Peto
Journal:  N Engl J Med       Date:  2008-02-13       Impact factor: 91.245

Review 8.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

9.  The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands.

Authors:  I Sutherland; E Svandová; S Radhakrishna
Journal:  Tubercle       Date:  1982-12

10.  Tuberculosis epidemics driven by HIV: is prevention better than cure?

Authors:  Christine S M Currie; Brian G Williams; Russell C H Cheng; Christopher Dye
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

View more
  23 in total

1.  Reconsidering global targets for tuberculosis control.

Authors:  B J Marais; P D van Helden
Journal:  Bull World Health Organ       Date:  2009-12       Impact factor: 9.408

2.  Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics.

Authors:  Reza Yaesoubi; Ted Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

Review 3.  Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.

Authors:  Molebogeng X Rangaka; Solange C Cavalcante; Ben J Marais; Sok Thim; Neil A Martinson; Soumya Swaminathan; Richard E Chaisson
Journal:  Lancet       Date:  2015-10-26       Impact factor: 79.321

4.  Disease elimination and re-emergence in differential-equation models.

Authors:  Scott Greenhalgh; Alison P Galvani; Jan Medlock
Journal:  J Theor Biol       Date:  2015-10-22       Impact factor: 2.691

5.  Implementing tuberculosis control in Papua New Guinea: a clash of culture and science?

Authors:  Kindin Ongugo; John Hall; John Attia
Journal:  J Community Health       Date:  2011-06

Review 6.  Priorities for tuberculosis research: a systematic review.

Authors:  Jamie Rylance; Madhukar Pai; Christian Lienhardt; Paul Garner
Journal:  Lancet Infect Dis       Date:  2010-11-01       Impact factor: 25.071

Review 7.  Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.

Authors:  E L Corbett; P MacPherson
Journal:  Int J Tuberc Lung Dis       Date:  2013-09       Impact factor: 2.373

8.  Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.

Authors:  S C Cavalcante; B Durovni; G L Barnes; F B A Souza; R F Silva; P F Barroso; C I Mohan; A Miller; J E Golub; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2010-02       Impact factor: 2.373

Review 9.  Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

Authors:  Peter MacPherson; Rein M G J Houben; Judith R Glynn; Elizabeth L Corbett; Katharina Kranzer
Journal:  Bull World Health Organ       Date:  2013-11-22       Impact factor: 9.408

10.  Cross-sectional studies of tuberculosis prevalence in Cambodia between 2002 and 2011.

Authors:  Tan Eang Mao; Kosuke Okada; Norio Yamada; Satha Peou; Masaki Ota; Saly Saint; Pichenda Kouet; Manith Chea; Sokonth Keo; Sok Heng Pheng; Sivanna Tieng; Kim Eam Khun; Tetsuhiro Sugamoto; Hiroko Matsumoto; Takashi Yoshiyama; Kunihiko Ito; Ikushi Onozaki
Journal:  Bull World Health Organ       Date:  2014-06-05       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.